We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Cap. Flow
-$5.56B
Cap. Flow
% of AUM
-11.64%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
2,131
New
54
Increased
334
Reduced
1,616
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$89.7M |
| 2 |
Fortinet
FTNT
|
+$69.3M |
| 3 |
Flowers Foods
FLO
|
+$37.9M |
| 4 |
Brown & Brown
BRO
|
+$28.6M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$626M |
| 2 |
Microsoft
MSFT
|
+$454M |
| 3 |
Apple
AAPL
|
+$414M |
| 4 |
Broadcom
AVGO
|
+$317M |
| 5 |
Amazon
AMZN
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.49% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Oric Pharmaceuticals
ORIC
$1.25B
| $161K | ﹤0.01% |
13,383
+1,527
| +13% | +$16.1K |
|
1752
QuinStreet
QNST
$870M
| $159K | ﹤0.01% |
10,296
-1,896
| -16% | -$30.1K |
|
1753
Geron
GERN
$911M
| $159K | ﹤0.01% |
116,136
-32,131
| -22% | -$42.8K |
|
1754
Nuvation Bio
NUVB
$2.24B
| $158K | ﹤0.01% |
42,675
-8,501
| -17% | -$23.2K |
|
1755
SFL Corp
SFL
$1.59B
| $156K | ﹤0.01% |
20,747
-4,135
| -17% | -$35.6K |
|
1756
Embecta
EMBC
$195M
| $156K | ﹤0.01% |
11,024
-2,037
| -16% | -$25.8K |
|
1757
NextDecade
NEXT
$1.85B
| $155K | ﹤0.01% |
22,881
-4,558
| -17% | -$44.1K |
|
1758
Immunome
IMNM
$2.52B
| $155K | ﹤0.01% |
13,194
-1,913
| -13% | -$19K |
|
1759
Anavex Life Sciences
AVXL
$222M
| $154K | ﹤0.01% |
17,354
-2,976
| -15% | -$30.2K |
|
|
ORC
1760
Orchid Island Capital
ORC
$1.31B
| $154K | ﹤0.01% |
21,909
-207
| -0.9% | -$1.47K |
|
1761
Tandem Diabetes Care
TNDM
$1.17B
| $153K | ﹤0.01% |
12,606
-2,313
| -16% | -$31.3K |
|
|
FFIC
1762
DELISTED
Flushing Financial
FFIC
| $152K | ﹤0.01% |
+11,028
| New | +$143K |
|
1763
Hertz
HTZ
$572M
| $152K | ﹤0.01% |
22,361
-4,108
| -16% | -$26.4K |
|
|
NPKI
1764
NPK International
NPKI
$1.21B
| $152K | ﹤0.01% |
13,428
-3,063
| -19% | -$29.8K |
|
1765
Red Cat Holdings
RCAT
$1.16B
| $151K | ﹤0.01% |
14,605
-749
| -5% | -$7K |
|
1766
Taysha Gene Therapies
TSHA
$1.59B
| $151K | ﹤0.01% |
46,039
+2,293
| +5% | +$6.49K |
|
1767
Utz Brands
UTZ
$1.25B
| $150K | ﹤0.01% |
12,383
-2,466
| -17% | -$32.7K |
|
1768
Relay Therapeutics
RLAY
$4.02B
| $150K | ﹤0.01% |
28,776
-4,781
| -14% | -$18.2K |
|
1769
ThredUp
TDUP
$736M
| $149K | ﹤0.01% |
15,812
-2,846
| -15% | -$26.9K |
|
1770
Kura Oncology
KURA
$922M
| $149K | ﹤0.01% |
16,880
-2,569
| -13% | -$18.3K |
|
1771
Evolv Technologies
EVLV
$943M
| $149K | ﹤0.01% |
19,774
-3,941
| -17% | -$28.8K |
|
1772
Arbutus Biopharma
ABUS
$865M
| $149K | ﹤0.01% |
32,715
-5,480
| -14% | -$20.1K |
|
1773
Yext
YEXT
$501M
| $148K | ﹤0.01% |
17,355
-3,830
| -18% | -$32.5K |
|
1774
Capitol Federal Financial
CFFN
$1.08B
| $147K | ﹤0.01% |
23,196
-4,289
| -16% | -$26.8K |
|
1775
3D Systems Corp
DDD
$420M
| $147K | ﹤0.01% |
50,705
-3,721
| -7% | -$7.67K |
|
Similar funds
ProShare Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, ProShare Advisors held 2,131 positions worth $47.8B, down 4.7% from $50.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors withdrew a net $5.56B in Q3 2025, closing 126 positions and reducing 1,616 holdings. Its most notable exit was Ansys, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, ProShare Advisors opened a new position in Thomson Reuters worth $75.8M.
- ProShare Advisors's largest Q3 2025 buy was Thomson Reuters: 480,707 shares worth $75.8M.
- ProShare Advisors added most to Fortinet in Q3 2025, an estimated $69.3M increase.
- ProShare Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $626M.
- ProShare Advisors fully exited Ansys in Q3 2025, selling an estimated $48.7M.
- ProShare Advisors's ten largest holdings make up 32% of its $47.8B portfolio in Q3 2025.
- ProShare Advisors opened 54 new positions and closed 126 in Q3 2025.
- ProShare Advisors's portfolio value fell 4.7% quarter-over-quarter to $47.8B.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.